Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development

Advances in immuno‐oncology have provided a variety of novel therapeutics that harness the innate immune system to identify and destroy neoplastic cells. It is noteworthy that acceptable safety profiles accompany the development of these targeted therapies, which result in efficacious cancer treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Kast, Johannes, Nozohouri, Saeideh, Zhou, Di, Yago, Marc R., Chen, Po‐Wei, Ahamadi, Malidi, Dutta, Sandeep, Upreti, Vijay V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468561/
https://www.ncbi.nlm.nih.gov/pubmed/35677992
http://dx.doi.org/10.1111/cts.13349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468561/
https://www.ncbi.nlm.nih.gov/pubmed/35677992
http://dx.doi.org/10.1111/cts.13349

Ejemplares similares